Position in JAZZ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$135,442,730
-$19,459,924 QoQ
Shares Held
562,073
-31.4% QoQ
Ownership
0.866%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,950,825,954 across 312 Biotechnology names. JAZZ ranks #5 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in JAZZ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $135,442,730 | 562,073 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $154,902,654 | 819,374 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $142,251,580 | 836,774 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $121,898,393 | 924,874 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $95,547,052 | 900,368 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $129,683,862 | 1,044,574 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $123,380,783 | 1,001,874 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $116,977,603 | 1,049,974 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $109,490,891 | 1,025,868 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $140,357,698 | 1,165,568 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $151,483,602 | 1,231,574 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $169,257,685 | 1,307,615 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $159,934,812 | 1,290,109 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $183,586,934 | 1,254,609 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $205,512,289 | 1,290,015 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $173,078,264 | 1,298,509 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $222,487,265 | 1,426,109 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $236,199,492 | 1,517,309 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $216,644,846 | 1,700,509 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $260,290,961 | 1,999,009 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $411,634,513 | 2,317,240 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $437,659,780 | 2,662,650 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $511,498,202 | 3,099,050 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $475,530,520 | 3,334,950 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $383,786,022 | 3,478,213 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $342,960,977 | 3,438,550 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||